On March 11, 2025, a federal judge in the Western District of North Carolina ruled in favor of Merck & Co. Inc. in litigation accusing the drugmaker of concealing the risks of Gardasil, its vaccine to prevent cervical and other cancers.
The court granted summary judgment to Merck against 'bellwether plaintiffs' in a multidistrict litigation, citing implied preemption by federal law. The ruling stated that Merck met the standard that it was 'impossible for a private party to comply with both state and federal requirements' regarding warnings.
This significant legal victory reduces potential liability for Merck related to its Gardasil vaccine. The decision reinforces the regulatory standard for vaccine warnings and supports Merck's long-held position on the safety and efficacy of its HPV vaccines.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.